View drug registration information details.

Items	Registration information
ID	265
No	265
Brand Name	AMOXICAP 250
Ingredients	AMOXYCILLIN TRIHYDRATE EQ.TO AMOXYCILLIN 250 MG
Dosage Form	CAPSULE
Primary Packaging	PVC/ALU BLISTER
Storage	STORE BELOW 30 C, PROTECT FROM LIGHT
Shelf Life	3 YEARS
Pack Size	BOX OF 10 X 10'S
Dispensing Category	Prescription only
ATC Classification	J01CA04
Pharmaceutical Class	ANTIBACTERIA
Indications	EAR, NOSE AND THROAT INFECTIONS CAUSED BY STREPTOCOCCI, PNEUMOCOCCI, NON-PENICILLINASE-PRODUCING STAPHYLOCOCCI AND H.INFLUENZA, GENITOURINARY TRACT INFECTION CAUSED BY E.COLI, P.MIRABILIS, S.FAECALIS, SKIN AND SOFT TISSUE INFECTION CAUSED BY STREPTOCOCCI, NON-PENICILLINASE-PRODUCING STAPHYLOCOCCI AND E.COLI, ANOGENITAL AND URETHRAL GONORRHOEA CAUSED BY N.GONORRHOEA
Contraindications	PATIENTS KNOWN TO BE SENSITIVE PENICILLIN, AVOID IN PATIENTS WITH INFECTIOUS MONONUCLEOSIS BECAUSE OF INCREASED RISK OF SKIN RASHES
Side Effects	RASH, HEMOLYTIC ANEMIA, ANEMIA, DIARRHEA, NAUSEA, VOMITING, BLACK HAIRY TONGUE, GLOSSITIS, STOMATITIS, SORE MOUTH OR TONGUE, ACUTE INTERSTITIAL NEPHRITIS
Unit Price	5.33
EDL	Yes
Description	SCARLET AND GREY CAPSULE WITH AX250 PRINTED ON ONE END AND HD PRINTED ON THE OTHER END, FILL MATERIAL: OFF-WHITE TO YELLOWISH POWDER
Note
License Owner	BMS PHARMA SOLE CO.,LTD
Manufacturer	HOVID BHD
Country	MALAYSIA
Import Registration No	MAL19900155AZ
Import Registration Date	2014-09-03
Activity	CERTIFICATE RELEASED
Applied Date	2020-12-11
FDD Registration No	08 I 5270/22
FDD Registration Date	2022-08-26
Expiry Date	2025-08-25

Back to drug list